These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 9511373

  • 1. [A monoclonal antibody panel for the intratypic differentiation of type-2 polioviruses].
    Shyrobokov VP, Nikolaienko IV, Kopanytsia LV, Solohub VK, Ivanova OIe.
    Mikrobiol Z; 1997; 59(6):27-36. PubMed ID: 9511373
    [Abstract] [Full Text] [Related]

  • 2. [Monoclonal antibodies used to differentiate between poliovirus types 1 and 3].
    Shirobokov VP, Kopanitsa LV, Nikolaenko IV, Lipatnikova KI, Sologub VK.
    Mikrobiol Z; 2001; 63(6):42-52. PubMed ID: 11944335
    [Abstract] [Full Text] [Related]

  • 3. Strain differentiation of polioviruses with monoclonal antibodies.
    Osterhaus AD, van Wezel AL, Stegmann AJ, van Asten JA, Hazendonk AG.
    Dev Biol Stand; 1984; 57():135-9. PubMed ID: 6098494
    [Abstract] [Full Text] [Related]

  • 4. Isolation of vaccine-derived type 1 polioviruses displaying similar properties to virulent wild strain Mahoney from sewage in Japan.
    Horie H, Yoshida H, Matsuura K, Miyazawa M, Wakabayashi K, Nomoto A, Hashizume S.
    J Med Virol; 2002 Nov; 68(3):445-51. PubMed ID: 12226835
    [Abstract] [Full Text] [Related]

  • 5. [A comparison of the diagnostic value of the virus neutralization reaction and of indirect immunoenzyme analysis using monoclonal antibodies for the intratype differentiation of vaccinal and virulent poliovirus strains].
    Nikolaienko IV.
    Lik Sprava; 1998 May; (3):84-6. PubMed ID: 9695574
    [Abstract] [Full Text] [Related]

  • 6. Analysis of antigenic profiles of inactivated poliovirus vaccine and vaccine-derived polioviruses by block-ELISA method.
    Rezapkin G, Martin J, Chumakov K.
    Biologicals; 2005 Mar; 33(1):29-39. PubMed ID: 15713554
    [Abstract] [Full Text] [Related]

  • 7. [Application of ELISA for screening McAb against type III polioviruses and its antigenic analysis].
    Gu FZ, Wang SH, Sun YY.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1985 Oct; 7(5):359-63. PubMed ID: 2421926
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mapping of type 1 poliovirus neutralization epitopes.
    Blondel B, Crainic R, Dufraisse G, Candréa A, Horaud F.
    Dev Biol Stand; 1985 Oct; 60():337-42. PubMed ID: 2412917
    [Abstract] [Full Text] [Related]

  • 10. Quantitation of D antigen content in inactivated poliovirus vaccine derived from wild-type or sabin strains.
    Sawyer LA, McInnis J, Albrecht P.
    Biologicals; 1993 Jun; 21(2):169-77. PubMed ID: 8297601
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Determination of type 1 poliovirus subtype classes with neutralizing monoclonal antibodies.
    Crainic R, Couillin P, Cabau N, Boue A, Horodniceanu F.
    Dev Biol Stand; 1981 Jun; 50():229-34. PubMed ID: 6176486
    [Abstract] [Full Text] [Related]

  • 13. Intratypic differentiation of poliovirus strains by enzyme-linked immunosorbent assay (ELISA): poliovirus type 1.
    Glikmann G, Moynihan M, Petersen I, Vestergaard BF.
    Dev Biol Stand; 1983 Jun; 55():199-208. PubMed ID: 6203794
    [Abstract] [Full Text] [Related]

  • 14. [Evaluation of an ELISA kit made in our laboratory for intratypic discrimination of poliovirus type 1 strains isolated from acute flask paralysis].
    Ozkaya E, Arita M.
    Mikrobiyol Bul; 2002 Jan; 36(1):71-7. PubMed ID: 12476769
    [Abstract] [Full Text] [Related]

  • 15. WHO collaborative study on the use of monoclonal antibodies for the intratypic differentiation of poliovirus strains.
    Ferguson M, Magrath DI, Minor PD, Schild GC.
    Bull World Health Organ; 1986 Jan; 64(2):239-46. PubMed ID: 3017595
    [Abstract] [Full Text] [Related]

  • 16. Quantitation of poliovirus antigens in inactivated viral vaccines by enzyme-linked immunosorbent assay using animal sera and monoclonal antibodies.
    Singer C, Knauert F, Bushar G, Klutch M, Lundquist R, Quinnan GV.
    J Biol Stand; 1989 Apr; 17(2):137-50. PubMed ID: 2541133
    [Abstract] [Full Text] [Related]

  • 17. Antigenic characterization of a formalin-inactivated poliovirus vaccine derived from live-attenuated Sabin strains.
    Tano Y, Shimizu H, Martin J, Nishimura Y, Simizu B, Miyamura T.
    Vaccine; 2007 Oct 10; 25(41):7041-6. PubMed ID: 17825459
    [Abstract] [Full Text] [Related]

  • 18. Production and characterization of neutralizing monoclonal antibodies against poliovirus type 1, 2, and 3.
    Payment P, Trudel M, Thibodeau L, Lecomte J.
    Can J Microbiol; 1989 May 10; 35(5):550-3. PubMed ID: 2545322
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Monoclonal antibodies of four different specificities for neutralization of type 1 polioviruses.
    Humphrey DD, Kew OM, Feorino PM.
    Infect Immun; 1982 May 10; 36(2):841-3. PubMed ID: 6282759
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.